Related Experiment Videos
Depression of spasticity by alpha-adrenergic blockade
Acta Neurologica Scandinavica
|January 1, 1978
Summary
The alpha-adrenergic blocking drug thymoxamine effectively reduced reflex activity in spastic patients. This spasmolytic agent shows promise for treating spasticity and clonus.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Spasticity is a common motor disorder characterized by increased muscle tone and exaggerated reflexes.
- Alpha-adrenergic pathways in the central nervous system (CNS) play a role in modulating motor reflexes.
Purpose of the Study:
- To investigate the effects of the alpha-adrenergic blocking drug thymoxamine on proprioceptive reflex parameters in spastic patients.
- To explore the potential of thymoxamine as a spasmolytic agent.
Main Methods:
- Intravenous administration of thymoxamine (Opilon Forte) to spastic patients.
- Assessment of proprioceptive reflex parameters within 1 minute post-administration.
- Evaluation of thymoxamine's effect on clonus following oral administration.
Main Results:
- Thymoxamine rapidly depressed most proprioceptive reflex parameters after intravenous administration.
- The drug's action is likely of CNS origin, potentially involving descending bulbospinal pathways and presynaptic inhibition.
- Oral thymoxamine administration effectively reduced distressing clonus.
Conclusions:
- Thymoxamine demonstrates significant spasmolytic potential by modulating CNS pathways.
- Further clinical investigation of thymoxamine is warranted for spasticity management.